<DOC>
	<DOCNO>NCT02194296</DOCNO>
	<brief_summary>Study investigate relative bioavailability 20 mg ambroxol hydrochloride lozenge compare 30 mg ambroxol hydrochloride syrup ( Mucosolvan® ) dose normalisation</brief_summary>
	<brief_title>Relative Bioavailability Ambroxol Hydrochloride Lozenge Comparison Ambroxol Hydrochloride Syrup ( Mucosolvan® ) Healthy Female Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ambroxol</mesh_term>
	<criteria>All participant study healthy male female Ages range 18 55 year Broca Index &gt; 20 % &lt; +20 % Prior admission study volunteer give write informed consent accordance Good Clinical Practice ( GCP ) local legislation Each subject medical history take receive complete medical examination ( incl . blood pressure pulse rate measurement ) well 12lead Electrocardiogram ( ECG ) Haematopoietic , hepatic renal function test carry laboratory The subject fast 12 hour collection specimens laboratory evaluation . The mentioned examination perform within 14 day first administration test substance Volunteers exclude study result medical examination laboratory test judge clinical investigator differ significantly normal clinical value Volunteers know gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic immunological hormonal disorder Volunteers diseases central nervous system ( epilepsy ) psychiatric disorder Volunteers know history orthostatic hypotension , faint spell blackouts Volunteers chronic relevant acute infection Volunteers history allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Volunteers take drug long halflife ( &gt; = 24 hour ) within one month enrolment study Volunteers receive drug might influence result trial week previous start study Volunteers participate another study investigational drug within last two month precede study Volunteers smoke ( 10 cigarette 3 cigar 3 pipes/day ) Volunteers able refrain smoking study day Volunteers drink 60 g alcohol per day Volunteers dependent drug Volunteers participate excessive physical activity ( e.g . competitive sport ) within last week study Volunteers donate blood ( &gt; 100 ml ) within last 4 week prior administration For female subject : Pregnancy Positive pregnancy test No adequate contraception e.g . sterilization , Intrauterine Devices ( IUD ) , oral contraceptive Inability maintain adequate contraception whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>